Yun Zhong
Stock Analyst at Wedbush
(2.43)
# 2,556
Out of 5,044 analysts
38
Total ratings
54.55%
Success rate
-0.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yun Zhong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics | Maintains: Outperform | $70 → $86 | $78.51 | +9.54% | 3 | Oct 28, 2025 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Outperform | $80 → $18 | $9.82 | +83.30% | 2 | Sep 30, 2025 | |
| PASG Passage Bio | Maintains: Outperform | $3 → $40 | $7.66 | +422.19% | 3 | Aug 13, 2025 | |
| SGMT Sagimet Biosciences | Initiates: Outperform | $28 | $8.24 | +239.81% | 1 | Aug 11, 2025 | |
| ASND Ascendis Pharma | Maintains: Outperform | $212 → $220 | $205.91 | +6.84% | 2 | Aug 8, 2025 | |
| VYGR Voyager Therapeutics | Maintains: Outperform | $9 → $8 | $4.66 | +71.67% | 2 | Aug 7, 2025 | |
| WVE Wave Life Sciences | Reiterates: Outperform | $18 | $7.59 | +137.15% | 1 | Jun 23, 2025 | |
| KROS Keros Therapeutics | Reiterates: Neutral | $15 | $15.18 | -1.19% | 2 | May 30, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | $8 | $3.91 | +104.60% | 1 | May 27, 2025 | |
| RCKT Rocket Pharmaceuticals | Reiterates: Outperform | $32 | $3.97 | +706.05% | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $9.49 | +26.45% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $28 | $8.10 | +245.68% | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.99 | - | 2 | Feb 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $8.86 | +80.59% | 1 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $160 | $24.22 | +560.61% | 11 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $46 | $70.00 | -34.29% | 1 | Jun 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.10 | +376.19% | 1 | May 5, 2021 |
Protagonist Therapeutics
Oct 28, 2025
Maintains: Outperform
Price Target: $70 → $86
Current: $78.51
Upside: +9.54%
MoonLake Immunotherapeutics
Sep 30, 2025
Maintains: Outperform
Price Target: $80 → $18
Current: $9.82
Upside: +83.30%
Passage Bio
Aug 13, 2025
Maintains: Outperform
Price Target: $3 → $40
Current: $7.66
Upside: +422.19%
Sagimet Biosciences
Aug 11, 2025
Initiates: Outperform
Price Target: $28
Current: $8.24
Upside: +239.81%
Ascendis Pharma
Aug 8, 2025
Maintains: Outperform
Price Target: $212 → $220
Current: $205.91
Upside: +6.84%
Voyager Therapeutics
Aug 7, 2025
Maintains: Outperform
Price Target: $9 → $8
Current: $4.66
Upside: +71.67%
Wave Life Sciences
Jun 23, 2025
Reiterates: Outperform
Price Target: $18
Current: $7.59
Upside: +137.15%
Keros Therapeutics
May 30, 2025
Reiterates: Neutral
Price Target: $15
Current: $15.18
Upside: -1.19%
Camp4 Therapeutics
May 27, 2025
Initiates: Outperform
Price Target: $8
Current: $3.91
Upside: +104.60%
Rocket Pharmaceuticals
May 16, 2025
Reiterates: Outperform
Price Target: $32
Current: $3.97
Upside: +706.05%
Nov 5, 2024
Initiates: Outperform
Price Target: $12
Current: $9.49
Upside: +26.45%
Feb 9, 2023
Maintains: Buy
Price Target: $35 → $28
Current: $8.10
Upside: +245.68%
Feb 2, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.99
Upside: -
Jan 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $8.86
Upside: +80.59%
Dec 22, 2022
Maintains: Buy
Price Target: $125 → $160
Current: $24.22
Upside: +560.61%
Jun 15, 2021
Initiates: Buy
Price Target: $46
Current: $70.00
Upside: -34.29%
May 5, 2021
Initiates: Buy
Price Target: $10
Current: $2.10
Upside: +376.19%